Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-005371
Filing Date
2024-08-08
Accepted
2024-08-08 16:01:24
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2024 sonoma_i10q-063024.htm   iXBRL 10-Q 548981
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8571
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8496
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4390
  Complete submission text file 0001683168-24-005371.txt   3549752

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20240630.xsd EX-101.SCH 26953
6 XBRL CALCULATION FILE snoa-20240630_cal.xml EX-101.CAL 50149
7 XBRL DEFINITION FILE snoa-20240630_def.xml EX-101.DEF 92797
8 XBRL LABEL FILE snoa-20240630_lab.xml EX-101.LAB 274448
9 XBRL PRESENTATION FILE snoa-20240630_pre.xml EX-101.PRE 227448
62 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-063024_htm.xml XML 386703
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 241188033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)